Meet the Precision
AQ team at Asembia's
AXS26 Pharmacy Summit

Las Vegas, Nevada | April 26-30, 2026
Asembia AXS26

Precision AQ is a commercialization partner for biopharma innovators, market access teams, and brand strategists. Working with clients from all 30 of the world’s top pharma companies, we specialize in turning data chaos into commercial clarity.

Our proprietary Access Made Possible technology integrates payer, provider, and patient insights to deliver scalable, actionable strategies that widen access to innovation. At Precision AQ, we believe access is earned with evidence, empathy, and precision.

Bridging Innovation and Access to Deliver Lasting Impact

From early evidence generation to payer engagement and patient affordability strategies, we help remove barriers to adoption and position your innovations for lasting success — delivering measurable value and meaningful impact where it matters most: in patients’ lives.

Our Market Access experts help teams understand payer decision-making and anticipate barriers before they emerge. We combine real-time payer intelligence with strategic analysis to support positioning, pull-through, and launch readiness. The result is a clear, evidence-backed path to broader patient access.

Alongside our Market Access experts, our U.S. Access Consulting team helps brands navigate national and regional payer environments with confidence. We bring together deep policy insight, payer expertise, and market evidence to guide strategy and anticipate shifts. Teams rely on us for clarity, speed, and targeted recommendations that support access at scale. Complete the form to book a meeting, and we’ll reach out to confirm the details.



Schedule a Meeting

GettyImages-1822285275-Woman_Child_Holding_Hands_Closeup-RET-1

And so much more!

We revolutionize healthcare by integrating cutting-edge technology with deep market insights to widen patient access and care.

Learn more about all of our services and products we can support your team in along the journey to patient access.

Explore our blog

Finding Lost-to-Follow-Up Patients Through EHR Precision: A Case Study
Navigating the New Frontier: How GUARD & GLOBE Will Transform Drug Pricing
2028 and Beyond: Winning JCA in Rare Diseases